Otsuka Holdings
4578.T
#618
Rank
ยฃ25.89 B
Marketcap
ยฃ47.91
Share price
-0.02%
Change (1 day)
62.91%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2023 (TTM): ยฃ1.97

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is ยฃ1.87. In 2022 the company made an earnings per share (EPS) of ยฃ1.41 a decrease over its 2021 EPS that were of ยฃ1.61.

EPS history for Otsuka Holdings from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ1.9739.55%
2022ยฃ1.41-12.38%
2021ยฃ1.61-18.58%
2020ยฃ1.9718.81%
2019ยฃ1.6655.85%
2018ยฃ1.07-25.05%
2017ยฃ1.4210.15%
2016ยฃ1.297.74%
2015ยฃ1.20-39.2%
2014ยฃ1.97-20.14%
2013ยฃ2.4751.58%
2012ยฃ1.63-6.65%
2011ยฃ1.7529.28%
2010ยฃ1.35